Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SV Health Investors
Biotech
Pharma-backed dementia fund raises $269M to invest in therapies
A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund.
James Waldron
May 20, 2025 9:48am
Investment firm secures $250M to help fund dementia drug R&D
Mar 20, 2025 2:53pm
Sanofi plucks new CSO from in-stealth biotech
Sep 24, 2024 10:44am
J&J, Google back inflammatory disease startup Mestag with $45M
Aug 3, 2021 12:18pm
TRexBio roars with dino-mite snags of CEO, CMO, Big Pharma cash
Jun 22, 2021 10:50am
Iveric Bio's executive chair, founder Guyer steps down
Apr 5, 2021 8:20am
